Management Team

Víctor Cervera-Carrascón

PhD, VP Scientific Affairs and External Strategy

Víctor Cervera-Carrascón, serves as Vice President (Scientific Affairs & External Strategy) at TILT Biotherapeutics. He brings over a decade of experience in oncology and immuno-oncology, spanning translational research, clinical development, business development, external partnerships, and scientific strategy. Víctor has played a key role in advancing TILT’s oncolytic immunotherapy platform from preclinical development into Phase II clinical trials and works closely with pharmaceutical partners, investors, and other external stakeholders.

Akseli Hemminki

MD, PhD, eMBA, Founder & CEO and Member of the Board of Directors

Suvi Sorsa

PhD, Chief Operating Officer

Hanna Kirk

MSc, VP Product Development

Henrik Roosvall

BSc, Head of Business Operations